Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Reddit
RDDT
|
+$196M |
| 2 |
Nike
NKE
|
+$183M |
| 3 |
Alibaba
BABA
|
+$172M |
| 4 |
Shopify
SHOP
|
+$167M |
| 5 |
TSMC
TSM
|
+$154M |
Top Sells
| 1 |
Palantir
PLTR
|
+$1.18B |
| 2 |
Microsoft
MSFT
|
+$678M |
| 3 |
Meta Platforms (Facebook)
META
|
+$350M |
| 4 |
Apple
AAPL
|
+$202M |
| 5 |
Micron Technology
MU
|
+$202M |
Sector Composition
| 1 | Technology | 20.89% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 14.08% |
| 4 | Industrials | 8.96% |
| 5 | Financials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
iShares MSCI India ETF
INDA
$9.5B
| $2.91M | ﹤0.01% |
55,300
-91,200
| -62% | -$4.8M |
|
1802
PotlatchDeltic
PCH
$3.12B
| $2.91M | ﹤0.01% |
74,099
-78,300
| -51% | -$3.07M |
|
1803
Dine Brands
DIN
$374M
| $2.9M | ﹤0.01% |
96,500
-158,200
| -62% | -$4.76M |
|
1804
Otter Tail
OTTR
$3.47B
| $2.9M | ﹤0.01% |
39,335
-19,975
| -34% | -$1.47M |
|
1805
Silvercrest Asset Management
SAMG
$136M
| $2.9M | ﹤0.01% |
157,537
-5,900
| -4% | -$109K |
|
1806
Acco Brands
ACCO
$370M
| $2.89M | ﹤0.01% |
549,700
+60,700
| +12% | +$319K |
|
1807
Entrada Therapeutics
TRDA
$194M
| $2.87M | ﹤0.01% |
166,200
+72,400
| +77% | +$1.25M |
|
1808
Republic Bancorp
RBCAA
$1.47B
| $2.87M | ﹤0.01% |
41,100
-300
| -0.7% | -$21K |
|
1809
Byline Bancorp
BY
$1.3B
| $2.87M | ﹤0.01% |
99,000
+40,900
| +70% | +$1.19M |
|
1810
Distribution Solutions Group
DSGR
$1.42B
| $2.87M | ﹤0.01% |
83,400
-9,145
| -10% | -$315K |
|
|
IAUX
1811
i-80 Gold Corp
IAUX
$747M
| $2.87M | ﹤0.01% |
5,910,533
+4,793,333
| +429% | +$2.32M |
|
1812
Enanta Pharmaceuticals
ENTA
$161M
| $2.86M | ﹤0.01% |
498,000
-26,900
| -5% | -$155K |
|
|
GRDN
1813
Guardian Pharmacy Services, Inc.
GRDN
$1.72B
| $2.86M | ﹤0.01% |
+141,100
| New | +$2.86M |
|
|
CMRX
1814
DELISTED
Chimerix, Inc.
CMRX
| $2.85M | ﹤0.01% |
820,349
-518,941
| -39% | -$1.81M |
|
1815
InfuSystem Holdings
INFU
$200M
| $2.85M | ﹤0.01% |
337,609
+8,700
| +3% | +$73.5K |
|
1816
Airgain
AIRG
$50.9M
| $2.85M | ﹤0.01% |
404,036
+39,436
| +11% | +$278K |
|
1817
Immunocore
IMCR
$1.68B
| $2.85M | ﹤0.01% |
96,570
-179,630
| -65% | -$5.3M |
|
1818
Priority Technology Holdings
PRTH
$584M
| $2.85M | ﹤0.01% |
242,200
+194,300
| +406% | +$2.28M |
|
1819
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.71B
| $2.84M | ﹤0.01% |
152,125
-393,036
| -72% | -$7.35M |
|
1820
Erasca
ERAS
$474M
| $2.84M | ﹤0.01% |
1,133,000
-158,000
| -12% | -$397K |
|
1821
Liberty Live Group Series A
LLYVA
$8.88B
| $2.84M | ﹤0.01% |
+42,600
| New | +$2.84M |
|
1822
United Parks & Resorts
PRKS
$2.78B
| $2.83M | ﹤0.01% |
50,400
+41,400
| +460% | +$2.33M |
|
1823
Schwab US Large-Cap Growth ETF
SCHG
$49.9B
| $2.83M | ﹤0.01% |
+101,600
| New | +$2.83M |
|
1824
Riley Exploration Permian
REPX
$613M
| $2.83M | ﹤0.01% |
88,615
+11,915
| +16% | +$380K |
|
|
GMRE
1825
Global Medical REIT
GMRE
$508M
| $2.83M | ﹤0.01% |
366,105
+42,005
| +13% | +$324K |
|